glp-1 side effects How To Manage GLP-1 Side Effects: 7 Important

Nadya Morrow is the recipient of a CIHR CGS-Doctoral Award

FFAs increased and positively correlated with 4-weekbody weight loss in mRYGB patients (Fig

A good prescriber will check for personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions

The manufacturer claims that 83% of adults taking Trimova lost 15% or more weight, and 48% of users lost at least 35% of their body weight

A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group

There is a need for more phase III studies to provide sufficient clinical evidence for the effectiveness of retatrutide, as current evidence is limited to phase II studies and has yet to prove its worth in a larger population